Parabilis Medicines, Inc. (PBLS)
37.20
+0.28
(+0.74%)
USD |
NASDAQ |
Sep 22, 12:04
Parabilis Medicines Price : 37.20 for Sept. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 41.58 | 42.32 | 34.72 | 36.93 | 1.706M |
| Sep 18, 2026 | 41.01 | 42.48 | 39.41 | 41.73 | 9.086M |
| Sep 17, 2026 | 37.51 | 42.22 | 37.35 | 40.88 | 1.093M |
| Sep 16, 2026 | 36.19 | 38.92 | 35.37 | 36.88 | 971054.0 |
| Sep 15, 2026 | 36.27 | 36.38 | 35.24 | 35.72 | 446231.0 |
| Sep 14, 2026 | 37.06 | 37.58 | 35.60 | 36.16 | 482361.0 |
| Sep 11, 2026 | 36.90 | 37.74 | 36.44 | 36.88 | 364815.0 |
| Sep 10, 2026 | 38.76 | 38.77 | 36.13 | 36.32 | 680768.0 |
| Sep 09, 2026 | 39.77 | 40.13 | 38.33 | 38.76 | 501251.0 |
| Sep 08, 2026 | 40.97 | 41.05 | 39.07 | 39.77 | 564705.0 |
| Sep 04, 2026 | 40.20 | 41.19 | 39.50 | 40.42 | 380843.0 |
| Sep 03, 2026 | 40.21 | 40.83 | 39.12 | 40.75 | 408283.0 |
| Sep 02, 2026 | 39.73 | 41.14 | 38.31 | 40.11 | 363945.0 |
| Sep 01, 2026 | 39.15 | 40.00 | 37.88 | 39.47 | 500168.0 |
| Aug 31, 2026 | 39.08 | 40.00 | 37.76 | 39.01 | 530036.0 |
| Aug 28, 2026 | 38.96 | 40.02 | 38.50 | 39.11 | 316256.0 |
| Aug 27, 2026 | 39.00 | 40.19 | 38.22 | 39.29 | 445443.0 |
| Aug 26, 2026 | 39.17 | 39.41 | 38.09 | 39.26 | 409252.0 |
| Aug 25, 2026 | 38.52 | 39.90 | 38.37 | 39.23 | 286099.0 |
| Aug 24, 2026 | 39.42 | 40.56 | 38.00 | 38.43 | 340273.0 |
| Aug 21, 2026 | 39.41 | 40.92 | 38.95 | 39.36 | 354614.0 |
| Aug 20, 2026 | 40.70 | 41.49 | 39.31 | 39.58 | 205807.0 |
| Aug 19, 2026 | 39.74 | 41.35 | 39.07 | 41.32 | 425141.0 |
| Aug 18, 2026 | 37.18 | 39.81 | 35.60 | 39.35 | 639143.0 |
| Aug 17, 2026 | 36.41 | 38.83 | 36.41 | 37.22 | 385405.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 71.46 |
| Oncolytics Biotech, Inc. | 0.7395 |
| Sangamo Therapeutics, Inc. | 0.1413 |
| Sarepta Therapeutics, Inc. | 20.96 |
| Anixa Biosciences, Inc. | 2.695 |
Price Related Metrics
| PS Ratio | 30375.58 |
| Price to Book Value | 4.386 |
| Earnings Yield | -5.14% |
| Market Cap | 4.596B |